United Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. United Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 20% to $2,327,500,000. The net income raised on $984,800,000 and profit margin reached 42%. Total operating expenses were $885,100,000.
Profit Margin
| 2014 | 1.28B | 340.07M | 26.39% |
|---|---|---|---|
| 2015 | 1.46B | 651.63M | 44.46% |
| 2016 | 1.59B | 713.7M | 44.64% |
| 2017 | 1.72B | 417.9M | 24.22% |
| 2018 | 1.62B | 589.2M | 36.2% |
| 2019 | 1.44B | -104.5M | -7.21% |
| 2020 | 1.48B | 514.8M | 34.71% |
| 2021 | 1.68B | 475.8M | 28.23% |
| 2022 | 1.93B | 727.3M | 37.56% |
| 2023 | 2.32B | 984.8M | 42.31% |
UTHR Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 2.32B | 1.93B | 1.68B | 1.48B | 1.44B | 1.62B | 1.72B | 1.59B | 1.46B | 1.28B |
Cost of revenue | 257.5M | 146.7M | 122.5M | 108.1M | 117.6M | 198.7M | 105.7M | 72.7M | 69.03M | 125.88M |
Gross profit | 2.07B | 1.78B | 1.56B | 1.37B | 1.33B | 1.42B | 1.61B | 1.52B | 1.39B | 1.16B |
Operating exp. | ||||||||||
Research and development | 408M | 322.9M | 540.1M | 357.7M | 1.18B | 357.9M | 264.6M | 147.6M | 245.09M | 242.54M |
Selling and marketing | 81.8M | 70.8M | 64.4M | 54.9M | 60.7M | 59.1M | 64.3M | 84.6M | 94.29M | 82M |
Total operating expenses | 885.1M | 809.9M | 1.00B | 781.6M | 1.51B | 623.7M | 594.7M | 464.4M | 697.71M | 623.83M |
Operating income | 1.18B | 979.7M | 555.9M | 593.6M | -187.6M | 805.4M | 814.9M | 1.06B | 699.01M | 538.8M |
Other income (expenses), net | 89.4M | -29.1M | 38M | 45.3M | 22.6M | -61.2M | -45.4M | 2.4M | 345.42M | -13.6M |
Income before tax | 1.27B | 950.6M | 593.9M | 638.9M | -165M | 758.9M | 769.5M | 1.06B | 1.04B | 525.18M |
Income tax expense | 289.5M | 223.3M | 118.1M | 124.1M | -60.5M | 169.7M | 351.6M | 346.5M | 392.79M | 185.10M |
Net income | 984.8M | 727.3M | 475.8M | 514.8M | -104.5M | 589.2M | 417.9M | 713.7M | 651.63M | 340.07M |
Earnings per share | ||||||||||
Basic EPS | 21.04 | 15.98 | 10.6 | 11.65 | -2.39 | 13.54 | 9.5 | 16.29 | 14.17 | 7.06 |
Diluted EPS | 19.81 | 15 | 10.06 | 11.54 | -2.39 | 13.39 | 9.31 | 15.25 | 12.72 | 6.28 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |